Viewing Study NCT00963495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2026-06-04 @ 7:13 PM
Study NCT ID: NCT00963495
Status: TERMINATED
Last Update Posted: 2015-06-22
First Post: 2009-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Acute Lymphocytic Leukemia View
None Chronic Lymphocytic Leukemia View
None Myelodysplasia View
None Lymphoma, Non-Hodgkin View
None Hodgkin's Lymphoma View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None clioquinol View
None relapsed and refractory hematologic malignancy View
None ALL View
None HD View
None CLL View
None High risk myelodysplasia (MDS) with an IPSS score >2.5 View
None CML blast crisis View
None Relapsed or refractory acute myeloid leukemia (AML) View